Cleared Traditional

NeuroQ 3.8 (K180077) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K180077 · Syntermed · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2018
Decision
218d
Days
Class 2
Risk

K180077 is an FDA 510(k) clearance for the NeuroQ 3.8. Classified as System, Tomography, Computed, Emission (product code KPS), Class II - Special Controls.

Submitted by Syntermed (Anaheim, US). The FDA issued a Cleared decision on August 16, 2018 after a review of 218 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1200 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Syntermed devices

Submission Details

510(k) Number K180077 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 10, 2018
Decision Date August 16, 2018
Days to Decision 218 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
111d slower than avg
Panel avg: 107d · This submission: 218d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KPS System, Tomography, Computed, Emission
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - KPS System, Tomography, Computed, Emission

All 177
Devices cleared under the same product code (KPS) and FDA review panel - the closest regulatory comparables to K180077.
VERITON CT whole body SPECT/CT system
K182484 · Spectrum Dynamics Medical, Ltd. · Nov 2018
Hybrid3D
K181468 · Hermes Medical Solutions AB · Oct 2018
uMI 550 PET/CT System
K182237 · Shanghai United Imaging Healthcare Co., Ltd. · Oct 2018
HeartSee Cardiac P.E.T. Processing Software
K181343 · Bracco Diagnostics, Inc. · Jun 2018
Biograph Vision
K180811 · Siemens Medical Solutions USA, Inc. · May 2018
VERITON NM
K180514 · Spectrum Dynamics Medical, Ltd. · Apr 2018